BIOEXTRAX AB (85X0) - Total Assets
Based on the latest financial reports, BIOEXTRAX AB (85X0) holds total assets worth €19.00 Million EUR (≈ $22.21 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See latest BIOEXTRAX AB stock price today for real-time trading data and today's change.
BIOEXTRAX AB - Total Assets Trend (2021–2025)
This chart illustrates how BIOEXTRAX AB's total assets have evolved over time, based on quarterly financial data. Also see BIOEXTRAX AB (85X0) cash conversion ratio for how efficiently the company converts equity into cash flow.
BIOEXTRAX AB - Asset Composition Analysis
Current Asset Composition (December 2025)
BIOEXTRAX AB's total assets of €19.00 Million consist of 22.4% current assets and 77.6% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 15.9% |
| Accounts Receivable | €28.00K | 0.1% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how BIOEXTRAX AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore BIOEXTRAX AB current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BIOEXTRAX AB's current assets represent 22.4% of total assets in 2025, a decrease from 90.3% in 2021.
- Cash Position: Cash and equivalents constituted 15.9% of total assets in 2025, down from 71.0% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 0.1% of total assets.
BIOEXTRAX AB Competitors by Total Assets
Key competitors of BIOEXTRAX AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gfl Environmental Holdings Inc
TO:GFL
|
Canada | CA$21.53 Billion |
|
Shanghai Environment Group Co Ltd
SHG:601200
|
China | CN¥30.85 Billion |
|
Science Environmental Protection Co. Ltd. A
SHG:688480
|
China | CN¥2.07 Billion |
|
Yonker Environmental Protect
SHE:300187
|
China | CN¥3.56 Billion |
|
Beijing ZEHO Waterfront Ecological Environment Treatment Co Ltd
SHG:605069
|
China | CN¥3.30 Billion |
|
BluMetric Environmental Inc
V:BLM
|
Canada | CA$37.09 Million |
|
Livium Ltd
AU:LIT
|
Australia | AU$19.84 Million |
|
Cleanaway Waste Management Ltd
AU:CWY
|
Australia | AU$7.13 Billion |
BIOEXTRAX AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.32 | 8.21 | 5.27 |
| Quick Ratio | 6.32 | 8.21 | 5.27 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €11.25 Million | €12.56 Million | €9.17 Million |
BIOEXTRAX AB - Advanced Valuation Insights
This section examines the relationship between BIOEXTRAX AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.95 |
| Latest Market Cap to Assets Ratio | 0.42 |
| Asset Growth Rate (YoY) | -14.7% |
| Total Assets | €24.73 Million |
| Market Capitalization | $10.42 Million USD |
Valuation Analysis
Below Book Valuation: The market values BIOEXTRAX AB's assets below their book value (0.42x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: BIOEXTRAX AB's assets decreased by 14.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for BIOEXTRAX AB (2021–2025)
The table below shows the annual total assets of BIOEXTRAX AB from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €24.73 Million ≈ $28.91 Million |
-14.72% |
| 2024-12-31 | €29.00 Million ≈ $33.90 Million |
+28.79% |
| 2023-12-31 | €22.52 Million ≈ $26.32 Million |
-40.62% |
| 2022-12-31 | €37.92 Million ≈ $44.33 Million |
+199.95% |
| 2021-12-31 | €12.64 Million ≈ $14.78 Million |
-- |
About BIOEXTRAX AB
Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. The company produces PHA (polyhydroxyalkanoates), a group of bio-based and biodegradable bioplastics that replace fossil-based plastics; PHBV, a stiff, high-performance polymer; and PHO, a soft, flexible, and smooth biopolymer with rubbery properties. It also provides hydrolysates protein for animal feed; … Read more